Author:
Schrappe M.,Reiter A.,Welte K.,Ludwig W.-D.,Harbott J.,Lampert F.,Henze G.,Riehm H.
Publisher
Springer Berlin Heidelberg
Reference21 articles.
1. Sallan SE, Gelber RD, Kimball V, Donnelly M, Cohen HJ (1990) More is better! Update of Dana-Farber Cancer Institute/Children’s Hospital childhood acute lymphoblastic leukemia trials. Haematol Blood Transfus 33: 459–466
2. Tubergen DG, Gilchrist GS, O’Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD (1993) Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children’s Cancer Group phase III trial. J Clin Oncol 11: 527–537
3. Reiter A, Schrappe M, Ludwig W-D, Hiddermann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84:3122–3133
4. Schmiegelow K, Pulczynska MK (1990) Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts? Am J Pediatr Hematol Oncol 12: 462–467
5. Schrappe M, Beck J, Brandeis WE, Feickert HJ, Gadner H, Graf N, Havers W, Henze G, Jobke A, Kornhuber B, Kiihl J, Lampert F, Miiller-Weihrich St, Niethammer D, Reiter A, Rister M, Ritter J, Schellong G, Tausch W, Weinel P, Riehm H (1987) Die Behandlung der akuten lymphoblastischen Leukamie im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM 81. Klin Padiatr 199: 133–150